Occudo Quantitative Strategies LP Takes Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Occudo Quantitative Strategies LP acquired a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 16,945 shares of the company's stock, valued at approximately $672,000.

A number of other hedge funds have also made changes to their positions in the company. Treasurer of the State of North Carolina grew its stake in Acadia Healthcare by 0.6% during the 4th quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company's stock valued at $1,586,000 after acquiring an additional 250 shares in the last quarter. Nisa Investment Advisors LLC boosted its holdings in shares of Acadia Healthcare by 40.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after purchasing an additional 301 shares during the last quarter. Coldstream Capital Management Inc. grew its position in shares of Acadia Healthcare by 4.9% in the fourth quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company's stock valued at $257,000 after purchasing an additional 303 shares in the last quarter. Covestor Ltd increased its holdings in shares of Acadia Healthcare by 27.2% in the fourth quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after purchasing an additional 310 shares during the last quarter. Finally, Pacer Advisors Inc. lifted its position in Acadia Healthcare by 2.4% during the fourth quarter. Pacer Advisors Inc. now owns 13,847 shares of the company's stock worth $549,000 after buying an additional 325 shares in the last quarter.

Acadia Healthcare Trading Up 2.0%

NASDAQ:ACHC traded up $0.51 during trading hours on Friday, reaching $26.15. 2,120,582 shares of the stock were exchanged, compared to its average volume of 1,707,626. Acadia Healthcare Company, Inc. has a twelve month low of $20.36 and a twelve month high of $82.41. The business has a 50-day moving average of $26.19 and a two-hundred day moving average of $35.54. The company has a market capitalization of $2.41 billion, a price-to-earnings ratio of 8.57, a PEG ratio of 1.46 and a beta of 1.01. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.05. The firm had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare's revenue was up .3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.84 EPS. On average, equities analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analysts Set New Price Targets

ACHC has been the subject of a number of recent research reports. Bank of America cut their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research note on Friday, February 28th. KeyCorp reduced their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday. Guggenheim started coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target for the company. Barclays reduced their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday. Finally, Royal Bank of Canada reduced their target price on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Acadia Healthcare has a consensus rating of "Moderate Buy" and an average price target of $47.94.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.